18:44:48 EDT Thu 13 Mar 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

SEC defendant Padilla's home targeted by prosecutors

2024-07-15 19:48 ET - Street Wire

Also Street Wire (U-ONPH) Oncology Pharma Inc

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

U.S. federal prosecutors have begun proceedings to collect the $6-million home of Joseph Padilla, a California man who pleaded guilty to criminal charges arising from an OTC Markets scheme that he ran through a Canadian brokerage. (All figures are in U.S. dollars.) Prosecutors said that Mr. Padilla was behind the manipulation of Oncology Pharma Inc., an OTC Markets company that claimed to be developing cancer treatments. That scheme and others he ran inflicted losses of at least $42.5-million on investors, the government said.

The request for Mr. Padilla's home is contained in a motion that prosecutors filed on July 11, 2024, in federal court in Boston. The motion comes about nine months after the judge sentenced Mr. Padilla to 5-1/2 years in prison for the scheme. As part of the sentencing, the judge imposed a $3-million forfeiture order, which prosecutors are seeking to satisfy through the sale of his home.

They say little about the home, but real estate advertising describes it as an 8,255-square-foot house with four bedrooms and seven bathrooms. It is located in Carlsbad, Calif., in the Rancho la Costa neighbourhood. The one-acre property includes an outdoor pool, and was last sold in 2005 for $1,125,000. (Mr. Padilla previously described the home as a $6-million one, but prosecutors say it is worth less than the $3-million forfeiture judgment. The difference may arise from a mortgage or other charge against the title.)

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2025 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.